United States · FDA National Drug Code directory
Ranolazine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70625-206_4dd57879-c7db-7079-e063-6294a90abcf7
- Product NDC
- 70625-206
- Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Composition / generic term
- RANOLAZINE
- Labeler
- SunGen Pharma LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20200401
- Source listing expiry
- 20271231
Source-listed ingredients
- RANOLAZINE — 500 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 29125 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOX (70625-206-00) · 70625-206-00
- 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (70625-206-01) · 70625-206-01
- 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (70625-206-02) · 70625-206-02
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →